Matches in Nanopublications for { ?s ?p "[Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 16 of
16
with 100 items per page.
- assertion description "[Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP59821.RAuVjbqzDPTjzaVFxwod4L9qjnMGZAjOYp8F6FqbIF1z4130_assertion description "[Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP59821.RAuVjbqzDPTjzaVFxwod4L9qjnMGZAjOYp8F6FqbIF1z4130_provenance.
- NP59906.RAoGxlNitMeDl4WfnF3Me6Ca7mu6innzhpQn5rt6mhbQk130_assertion description "[Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP59906.RAoGxlNitMeDl4WfnF3Me6Ca7mu6innzhpQn5rt6mhbQk130_provenance.
- NP229236.RAjDUH0hoO4lThwbTDqEdOYxOadzCeoSgGdNwQdPoS7PM130_assertion description "[Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP229236.RAjDUH0hoO4lThwbTDqEdOYxOadzCeoSgGdNwQdPoS7PM130_provenance.
- NP105509.RAmAiwqjfO6KsNRaM4G9VihVyKMyeOJoo8Xhxq2xG0vGA130_assertion description "[Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105509.RAmAiwqjfO6KsNRaM4G9VihVyKMyeOJoo8Xhxq2xG0vGA130_provenance.
- NP105510.RAjv9PDiQm7qEWEcUq-0WFkhcj4GWgX0aYils0fj_IpWw130_assertion description "[Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105510.RAjv9PDiQm7qEWEcUq-0WFkhcj4GWgX0aYils0fj_IpWw130_provenance.
- NP593907.RAox6eCxesPHp4wO-m-NGC1DhnVmoo76QgO3iS6Cfg2DA130_assertion description "[Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593907.RAox6eCxesPHp4wO-m-NGC1DhnVmoo76QgO3iS6Cfg2DA130_provenance.
- NP593908.RAlRlYJvenKrcw3J3KzKMjRmJQnjR83eCx3PGxkJZi8ao130_assertion description "[Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593908.RAlRlYJvenKrcw3J3KzKMjRmJQnjR83eCx3PGxkJZi8ao130_provenance.
- NP105508.RAJGhVasBFIhI7PkRwjOz8xf6Ec3hgPtUH4Zyfm9zUVGo130_assertion description "[Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105508.RAJGhVasBFIhI7PkRwjOz8xf6Ec3hgPtUH4Zyfm9zUVGo130_provenance.
- NP593911.RAMMwW8nHZIV4pGPvJcM5ySF1ApIJAz4TCQKga7rmFjj8130_assertion description "[Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593911.RAMMwW8nHZIV4pGPvJcM5ySF1ApIJAz4TCQKga7rmFjj8130_provenance.